Figure 1
In vivo efficacy of anti–CD79b-vcMMAE in a BJAB xenograft model of lymphoma with a starting tumor volume of approximately 200 mm3. Ten mice per group were treated with 2 mg ADC/kg mouse of antibody as indicated.
In vivo efficacy of anti–CD79b-vcMMAE in a BJAB xenograft model of lymphoma with a starting tumor volume of approximately 200 mm3. Ten mice per group were treated with 2 mg ADC/kg mouse of antibody as indicated.
